BR9916735A - Compostos de 3-heteroarilidenil-2-indolinona para a modulação da atividade das cinases protéicas e para uso na quimioterapia do cancêr - Google Patents

Compostos de 3-heteroarilidenil-2-indolinona para a modulação da atividade das cinases protéicas e para uso na quimioterapia do cancêr

Info

Publication number
BR9916735A
BR9916735A BR9916735-2A BR9916735A BR9916735A BR 9916735 A BR9916735 A BR 9916735A BR 9916735 A BR9916735 A BR 9916735A BR 9916735 A BR9916735 A BR 9916735A
Authority
BR
Brazil
Prior art keywords
heteroarylidenyl
protein kinase
cancer chemotherapy
indolinone compounds
kinase activity
Prior art date
Application number
BR9916735-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Peter J Langecker
Laura Kay Shawver
Peng Cho Tang
Li Sun
Original Assignee
Sugen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sugen Inc filed Critical Sugen Inc
Publication of BR9916735A publication Critical patent/BR9916735A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9916735-2A 1998-12-31 1999-12-30 Compostos de 3-heteroarilidenil-2-indolinona para a modulação da atividade das cinases protéicas e para uso na quimioterapia do cancêr BR9916735A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11431398P 1998-12-31 1998-12-31
PCT/US1999/031232 WO2000038519A1 (en) 1998-12-31 1999-12-30 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy

Publications (1)

Publication Number Publication Date
BR9916735A true BR9916735A (pt) 2001-09-25

Family

ID=22354480

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916735-2A BR9916735A (pt) 1998-12-31 1999-12-30 Compostos de 3-heteroarilidenil-2-indolinona para a modulação da atividade das cinases protéicas e para uso na quimioterapia do cancêr

Country Status (10)

Country Link
EP (1) EP1139754A4 (ja)
JP (1) JP2002533360A (ja)
KR (1) KR20010108063A (ja)
CN (1) CN1356872A (ja)
AU (1) AU760964B2 (ja)
BR (1) BR9916735A (ja)
CA (1) CA2357042A1 (ja)
IL (1) IL143920A0 (ja)
MX (1) MXPA01006742A (ja)
WO (1) WO2000038519A1 (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569868B2 (en) 1998-04-16 2003-05-27 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
US6878733B1 (en) 1999-11-24 2005-04-12 Sugen, Inc. Formulations for pharmaceutical agents ionizable as free acids or free bases
WO2001037820A2 (en) * 1999-11-24 2001-05-31 Sugen, Inc. Ionizable indolinone derivatives and their use as ptk ligands
CZ303705B6 (cs) * 2000-02-15 2013-03-27 Sugen, Inc. Pyrrolem substituovaná 2-indolinonová sloucenina pro pouzití jako inhibitor proteinkináz a farmaceutická kompozice s jejím obsahem
NZ520593A (en) * 2000-02-28 2004-10-29 Aventis Pharma S A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
MY128450A (en) 2000-05-24 2007-02-28 Upjohn Co 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
US6706709B2 (en) 2000-06-02 2004-03-16 Sugen, Inc. Indolinone derivatives as protein kinase/phosphatase inhibitors
BRPI0207961B8 (pt) 2001-03-14 2021-05-25 Bristol Myers Squibb Co uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
US6599902B2 (en) 2001-05-30 2003-07-29 Sugen, Inc. 5-aralkysufonyl-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
AR038957A1 (es) * 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
WO2003035614A2 (en) * 2001-10-25 2003-05-01 Merck & Co., Inc. Tyrosine kinase inhibitors
WO2003035616A2 (en) * 2001-10-25 2003-05-01 Merck & Co., Inc. Tyrosine kinase inhibitors
WO2003035619A1 (en) * 2001-10-25 2003-05-01 Merck & Co., Inc. Tyrosine kinase inhibitors
WO2003045307A2 (en) * 2001-11-21 2003-06-05 Sugen, Inc. Pharmaceutical formulations comprising indolinone derivatives
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
US6797825B2 (en) 2001-12-13 2004-09-28 Abbott Laboratories Protein kinase inhibitors
AU2002360753B2 (en) 2001-12-27 2008-08-21 Theravance, Inc. Indolinone derivatives useful as protein kinase inhibitors
CN1662234A (zh) 2002-06-25 2005-08-31 惠氏公司 硫代－羟吲哚衍生物在治疗与激素有关的病症中的用途
EP1515680A4 (en) 2002-06-25 2005-09-21 Wyeth Corp USE OF THIO-OXINDOLE DERIVATIVES IN THE TREATMENT OF SKIN DISORDERS
KR101036866B1 (ko) 2002-08-02 2011-05-25 에이비 사이언스 2-(3-아미노아릴)아미노-4-아릴-티아졸 및 ｃ-ｋｉｔ억제제로서의 이의 용도
US8450302B2 (en) 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
WO2004045617A1 (en) * 2002-11-15 2004-06-03 Warner-Lambert Company Llc Combination chemotherapy comprising a mek inhibitor and capecitabine for treating cancer
CA2542909C (en) 2003-10-23 2012-07-10 Ab Science 2-aminoaryloxazole compounds as tyrosine kinase inhibitors
CN100432071C (zh) * 2004-11-05 2008-11-12 中国科学院上海药物研究所 取代1h－吲哚－2－酮类化合物及其制备方法和用途
UA95071C2 (ru) 2005-04-04 2011-07-11 Аб Сьянс Замещенные производные оксазола и их применение как ингибиторов тирозинкиназы
US8246966B2 (en) 2006-08-07 2012-08-21 University Of Georgia Research Foundation, Inc. Trypanosome microsome system and uses thereof
CA2669531A1 (en) 2006-11-22 2008-06-05 University Of Georgia Research Foundation, Inc. Tyrosine kinase inhibitors as anti-kinetolastid and anti-apicomplexan agents
HUE037928T2 (hu) * 2011-11-11 2018-09-28 Lilly Co Eli Kombinációs terápia petefészekrák ellen
US11083755B2 (en) 2015-01-08 2021-08-10 The Board Of Trustees Of The Leland Stanford Junior University Factors and cells that provide for induction of bone, bone marrow, and cartilage
SI3288940T1 (sl) 2015-04-29 2021-07-30 Janssen Pharmaceutica Nv Azabenzimidazoli in njihova uporaba kot modulatorji AMPA-receptorja
CN105585558A (zh) * 2015-12-15 2016-05-18 贵州大学 双烷氧基嘧啶拼接3-烯键氧化吲哚衍生物及其制备方法及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
WO1998007695A1 (en) * 1996-08-23 1998-02-26 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease

Also Published As

Publication number Publication date
MXPA01006742A (es) 2004-04-21
JP2002533360A (ja) 2002-10-08
WO2000038519A1 (en) 2000-07-06
AU2221500A (en) 2000-07-31
KR20010108063A (ko) 2001-12-07
AU760964B2 (en) 2003-05-22
IL143920A0 (en) 2002-04-21
CA2357042A1 (en) 2000-07-06
CN1356872A (zh) 2002-07-03
EP1139754A1 (en) 2001-10-10
EP1139754A4 (en) 2002-12-18

Similar Documents

Publication Publication Date Title
BR9916735A (pt) Compostos de 3-heteroarilidenil-2-indolinona para a modulação da atividade das cinases protéicas e para uso na quimioterapia do cancêr
PA8515701A1 (es) Compuestos, composiciones farmaceuticas y metodos para inhibir kinasas proteinicas
BR9910792A (pt) Inibidores de quinase protéica 2-indolinona substituìda com pirrol
PT1017384E (pt) Compostos com base no azabenzimidazole para modulacao da funcao de uma cinase de proteina serina/treonina
BR9814814A (pt) Processos para modular função de quinase de proteìna serina/treonina com compostos à base de 5-azaquinoxalina
BR9915210A (pt) N-aril-amidas de ácido antranìlico-e ácido tioantranìlico
BR9813028A (pt) Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos
BRPI0007487B8 (pt) difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
EP0984930A4 (en) 2-INDOLINE DERIVATIVES AS MODULATORS OF THE PROTEIN KINASE ATIVITY
CR20120009A (es) 2-indolinonas sustituidas con pirrolos inhibidores de proteinquinasas (divisional exp. 6728)
BR9713338A (pt) Benzonaftiridinas como terapêuticos brÈnquicos.
WO2000008202A3 (en) 3-methylidenyl-2-indolinone modulators of protein kinase
BR0107643A (pt) Composições e processos para a terapia e diagnóstico de c ncer de próstata
BR9811956A (pt) Naftiridinonas para a inibição de proteìna tirosina cinase e de proliferação celular mediada por cinase de ciclo de célula
TR200001312T2 (tr) Benzotiyazol protein tirozin kinaz önleyicileri.
BR0009670A (pt) Métodos de induzir morte de células de câncer e regressão de tumor
BR9806752A (pt) Ftalazinonas.
BR9805544C1 (pt) Uso de um composto.
BR0013081A (pt) Pirimidino-2,4,6-trionas inibidoras de metaloproteinases
BR9808697A (pt) Processo para inibir o crescimento de um tumor, vetor de adenovìrus defeituoso, vetor de vìrus, uso do mesmo, e, composição farmacêutica
DK1104425T3 (da) Hidtil ukendte thiazolopyrimidinforbindelser
BR0316296A (pt) Compostos lapacone e seus métodos de uso
GT200300294A (es) Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso
BR9913190A (pt) Modulação de proteìnas quinase de linhagemmúltipla

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.